Acyclovir carries the risk of causing acute nephropathy.
[Acute renal failure with acyclovir in a 42-year-old patient without previous renal dysfunction].
AI Summary
Key Findings
Abstract
INTRODUCTION: Herpetic meningoencephalitis is treated with acyclovir (15 mg/kg/8 h). This higher dosage enhance the risk of acute renal failure. CASE REPORT: We report the case of a previously healthy 42 years old man treated by intravenous aciclovir 1g/8 h for a herpetic meningoencephalitis. He presented an acute renal failure and an acute confusional state at the end of the treatment. Renal function and neurologic status improved rapidly with increased hydration and stop of the antiviral therapy. CONCLUSION: If acyclovir is usually well tolerated, there is also a risk of acute nephropathy, especially dose-dependent. We point out the need to monitor renal function when high dosage of acyclovir is indicated.
Affiliation
Centre régional de pharmacovigilance, CHU de Côte-de-Nacre, 14033 Caen cedex, France. [email protected]
External References
- PubMed ID:
- 16854507
Comments
Sign in or create a free account to join the conversation.
Sign in to commentBe the first to comment.